Condition
Pituitary Tumor
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownGenetic Bases of Neuroendocrine Neoplasms in Mexican PatientsNCT06523582 · 2022-08-03
RECRUITINGElectrophysiology of the Human Pituitary GlandNCT05338125 · 2020-12-10
TERMINATEDCopeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary SurgeryNCT04369703 · 2020-01-28
COMPLETEDSeoul National University Pituitary Disease Cohort StudyNCT03474601 · 2015-03-15
UNKNOWNCommon interventions
Leading sponsors
Trial status mix
COMPLETED1
RECRUITING1
TERMINATED1
UNKNOWN1
Phase mix
NA1
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.